OnKure Therapeutics (OKUR) Operating Leases (2022 - 2026)
OnKure Therapeutics' (OKUR) quarterly Operating Leases came in at $120000.0 in Q3 2025, down 68.34% YoY from $379000.0 in Q3 2024, and down 55.06% on a QoQ basis from $267000.0 in Q2 2025.
OnKure Therapeutics (OKUR) Operating Leases (2022 - 2026) Analysis & Trends
OnKure Therapeutics (OKUR) has 4 years of Operating Leases data on file, last reported at $120000.0 in Q3 2025.
- Quarterly Operating Leases fell 68.34% year-over-year to $120000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $120000.0 (down 68.34% YoY) and the FY2024 annual result came in at $549000.0, up 17.81% from the prior year.
- Operating Leases declined to $120000.0 in Q3 2025, from $267000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $1.1 million in Q1 2022 to a low of $120000.0 in Q3 2025.
- A 4-year average of $675733.3 and a median of $576000.0 in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2024 — Operating Leases gained 17.81% — and 2025, when it sank 68.34%.
- Tracing OKUR's Operating Leases over 4 years: stood at $1.1 million in 2022, then sank by 56.0% to $466000.0 in 2023, then gained by 17.81% to $549000.0 in 2024, then tumbled by 78.14% to $120000.0 in 2025.
- The last three Operating Leases figures came in at $120000.0 (Q3 2025), $267000.0 (Q2 2025), and $409000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | OnKure Therapeutics | 196.98 Mn | 20.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 590,000.00 |
| Sep 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 267,000.00 |
| Mar 31, 2025 | 409,000.00 |
| Dec 31, 2024 | 549,000.00 |
| Sep 30, 2024 | 379,000.00 |
| Jun 30, 2024 | 492,000.00 |
| Mar 31, 2024 | 576,000.00 |
| Dec 31, 2023 | 466,000.00 |
| Sep 30, 2023 | 812,000.00 |
| Jun 30, 2023 | 897,000.00 |
| Mar 31, 2023 | 979,000.00 |
| Dec 31, 2022 | 1.06 Mn |
| Sep 30, 2022 | 943,000.00 |
| Jun 30, 2022 | 1.06 Mn |
| Mar 31, 2022 | 1.13 Mn |